Blackbryont Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ernakulam, Kerala, India, established in 2009.
2009 Ernakulam, Kerala, India Active
Last Updated:
Access Report
About Blackbryont Pharmaceuticals Private Limited

Blackbryont Pharmaceuticals Private Limited, a active private limited company, was established on 30 September 2009 in Ernakulam, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KL2009PTC024806. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.60 M.

It upholds a compliant status. Its leadership includes Sivasankara Menon Biju (Additional Director), Sugunan Mathilakath (Director), Ravindran Thekkedath (Director). Past directors included Rajananda Govindaraj, Sivadas Gopi, Kunnamtodi Anish. It holds ₹3.91 M open charges and ₹3.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.38/905-A(Old 34/1131-A1) Balakrishna Menon Road Edappally.P.O ., Cochin-682024, Ernakulam, Kerala, 682024.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232KL2009PTC024806

  • Registration Number

    024806

  • Incorporation Date

    30 September 2009

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹2.60 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 2.60 M
  • Company Age 16 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.91 M
  • Satisfied Charges ₹ 3.50 M
  • Revenue Growth **** 40.29%
  • Profit Growth **** -72.95%
  • Ebitda **** -31.97%
  • Net Worth 12.03%
  • Total Assets **** 12.58%
Company report

Blackbryont Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Blackbryont Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Blackbryont Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sivasankara Menon Biju Additional Director 01 Jun 2014 Current
Sugunan Mathilakath Director 30 Sep 2009 Current
Ravindran Thekkedath Director 30 Sep 2009 Current
Sivadas Gopi Director 13 Dec 2017 Current
Shibu Kurian Additional Director 01 Apr 2013 Current
Manoj Valiya Parakkatt Director 13 Dec 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Dec 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Director 13 Mar 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Director 10 Apr 2019 Past
Pramod Abcsdd Additional Director 20 Jul 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Blackbryont Pharmaceuticals.

Blackbryont Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.29% increase. The company also saw a substantial fall in profitability, with a 72.95% decrease in profit. The company's net worth Soared by an impressive increase of 12.03%.

Blackbryont Pharmaceuticals revenue growth over time
Blackbryont Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 40.29%
*******
*******
*******
*******
Revenue from Operations
*******
 40.30%
*******
*******
*******
*******
Total Assets
*******
 12.58%
*******
*******
*******
*******
Profit or Loss
*******
 -72.95%
*******
*******
*******
*******
Net Worth
*******
 12.03%
*******
*******
*******
*******
EBITDA
*******
 -31.97%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Blackbryont Pharmaceuticals?

In 2023, Blackbryont Pharmaceuticals had a public holding of 7.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,906,761.00

Satisfied Charges

₹3,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.32 Cr
  • Hdfc Bank Limited : 0.07 Cr
Latest Charge Details
Date Lender Amount Status
27 Jun 2024 Others ₹3.20 M Open
03 Mar 2021 Hdfc Bank Limited ₹0.71 M Open
20 Oct 2020 Uco Bank ₹3.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Blackbryont Pharmaceuticals?

Unlock and access historical data on people associated with Blackbryont Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blackbryont Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blackbryont Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Blackbryont Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Blackbryont Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Blackbryont Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 20 Oct 2020 via Charge ID 100398980 with Uco Bank was fully satisfied on 13 Aug 2024. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 3.20 M with Charge ID 100967039 was registered on 27 Jun 2024. was completed.

  • Charges

    Progress on A charge with Uco Bank of Rs. 3.50 M registered on 20 Oct 2020 with Charge ID 100398980 was modified on 20 Jan 2024. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.71 M with Charge ID 100455785 was registered on 03 Mar 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Blackbryont Pharmaceuticals Private Limited?

The CIN of Blackbryont Pharmaceuticals Private Limited is U24232KL2009PTC024806.

Where is Blackbryont Pharmaceuticals Private Limited headquartered?

Blackbryont Pharmaceuticals Private Limited is headquartered at No.38/905-A(Old 34/1131-A1) Balakrishna Menon Road Edappally.P.O ., Cochin-682024, Ernakulam, Kerala, 682024.

When was Blackbryont Pharmaceuticals Private Limited incorporated?

Blackbryont Pharmaceuticals Private Limited was incorporated on 30 September 2009.

Who are the current directors of Blackbryont Pharmaceuticals Private Limited?

The current directors of Blackbryont Pharmaceuticals Private Limited are

What is the primary industry of Blackbryont Pharmaceuticals Private Limited?

The primary industry of Blackbryont Pharmaceuticals Private Limited is Manufacturing.

Is Blackbryont Pharmaceuticals Private Limited a listed company?

Blackbryont Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Blackbryont Pharmaceuticals Private Limited?

The authorized capital of Blackbryont Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹2.60 M.

What is the compliance status of Blackbryont Pharmaceuticals Private Limited?

The compliance status of Blackbryont Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available